Search Results - "Fuchsluger, T"

Refine Results
  1. 1

    Biomaterials for ocular surface reconstruction and lamellar keratoplasty by Fuchsluger, T.

    Published in Acta ophthalmologica (Oxford, England) (01-10-2015)
    “…Summary This presentation present strategies to engineer a biomatrix through nanofibers. Different characteristics of the fibers and the matri, f.ex…”
    Get full text
    Journal Article
  2. 2

    New developments in DMEK and endothelial cell therapy by Fuchsluger, T.

    Published in Acta ophthalmologica (Oxford, England) (01-10-2015)
    “…Summary This presentation provides an overview of current and future developments in endothelial transplantation. Aspects of clinical innovation,…”
    Get full text
    Journal Article
  3. 3

    The Biocompatibility Analysis of Artificial Mucin-Like Glycopolymers by Trosan, P, Tang, J. S. J, Rosencrantz, R. R, Daehne, L, Smaczniak, A. Debrassi, Staehlke, S, Chea, S, Fuchsluger, T. A

    “…The ocular surface is covered by a tear film consisting of an aqueous/mucin phase and a superficial lipid layer. Mucins, highly O-glycosylated proteins, are…”
    Get full text
    Journal Article
  4. 4

    Anti-apoptotic gene therapy prolongs survival of corneal endothelial cells during storage by Fuchsluger, T A, Jurkunas, U, Kazlauskas, A, Dana, R

    Published in Gene therapy (01-08-2011)
    “…Corneal transplantation is the most common form of grafting performed worldwide. Corneal endothelial cells (EC) form a monolayer in the posterior portion of…”
    Get full text
    Journal Article
  5. 5

    Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification by Barabino, S, Benitez-Del-Castillo, J M, Fuchsluger, T, Labetoulle, M, Malachkova, N, Meloni, M, Utheim, T P, Rolando, M

    “…The aim of this review is to summarize the results of a consensus meeting held by a group of experts in dry eye disease (DED) to discuss the importance of tear…”
    Get more information
    Journal Article
  6. 6

    Viral and non‐viral vectors for cell and gene therapy of the corneal endothelium by Fuchsluger, T., Grünert, A., Mahajan, S., Czugala, M.

    Published in Acta ophthalmologica (Oxford, England) (01-09-2017)
    “…Summary This presentation highlights non‐viral and viral vector strategies to modify corneal endothelial cells. Functional data will be presented…”
    Get full text
    Journal Article
  7. 7

    Novel concepts in corneal reconstruction by Fuchsluger, T., Stafiej, P., Florian, K., Schubert, D.

    Published in Acta ophthalmologica (Oxford, England) (01-09-2017)
    “…Summary This presentation will present new approaches regarding biomaterials for ocular surface reconstruction…”
    Get full text
    Journal Article
  8. 8

    Acanthamoeba keratitis – pKP versus conservative treatment in a 20‐year follow‐up study by Fuchsluger, T., Scheumann, A., Roth, A., Klammann, A., Geerling, G.

    Published in Acta ophthalmologica (Oxford, England) (01-09-2017)
    “…Summary This presentation reports data from conservative versus surgical treatment of acanthamoeba cases collected at Dusseldorf University Eye Hospital over…”
    Get full text
    Journal Article
  9. 9

    Crosslinking and corneal biomechanics by Fuchsluger, T., Brettl, S., Geerling, G., Philipp, F.Z.

    Published in Acta ophthalmologica (Oxford, England) (01-09-2017)
    “…Summary This presentation will demonstrate data on corneal biomechanics measured with the CORVIS ST (Oculus GmbH, Wetzlar, Germany) to evaluate normal corneas,…”
    Get full text
    Journal Article
  10. 10

    Magnetized nanoparticles for transfection of the corneal endothelium by Fuchsluger, T., Mykhailyk, O., Christian, P., Singer, B., Czugala, M.

    Published in Acta ophthalmologica (Oxford, England) (01-10-2016)
    “…Summary This talk will present principles of transfection of corneal cells with magnetized nanoparticles. Transfecton efficiencies, particles preparations,…”
    Get full text
    Journal Article
  11. 11

    Self‐complementary vectors for optimization of AAV2‐mediated gene‐therapy of corneal endothelial cells by Gruenert, A., Buening, H., Schnoedt, M., Schmeer, M., Schleef, M., Kruse, F.E., Fuchsluger, T.

    Published in Acta ophthalmologica (Oxford, England) (01-10-2015)
    “…Purpose Recombinant adeno‐associated viruses 2 (rAAV2) represent a nonpathogenic and safe alternative to other viral delivery systems. However, their…”
    Get full text
    Journal Article
  12. 12

    New nanofibrous scaffold for corneal tissue engineering by Salehi, S, Grünert, A K, Bahners, T, Gutmann, J S, Steuhl, K P, Czugala, M, Singer, B B, Fuchsluger, T A

    Published in Klinische Monatsblatter fur Augenheilkunde (01-06-2014)
    “…An estimated 10 million people suffer worldwide from vision loss caused by corneal damage. For the worst cases, the only available treatment is transplantation…”
    Get more information
    Journal Article
  13. 13

    Viral vectors for gene delivery to corneal endothelial cells by Fuchsluger, T A, Jurkunas, U, Kazlauskas, A, Dana, R

    Published in Klinische Monatsblatter fur Augenheilkunde (01-06-2011)
    “…Corneal endothelium is an interesting target for in vitro gene transfer strategies as it is readily accessible thanks to its anatomic structure as a monolayer…”
    Get more information
    Journal Article
  14. 14

    Gene therapy in ophthalmology: state of the art by Kovtun, A, Epple, M, Steuhl, K P, Erguen, S, Fuchsluger, T

    Published in Klinische Monatsblatter fur Augenheilkunde (01-06-2012)
    “…The term "gene therapy" denotes the treatment of diseases or gene deficiencies by introduction of genes into cells. To achieve this goal, vectors are used to…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Protection of corneal endothelium from apoptosis by gene and cell therapy by Fuchsluger, T A

    “…Protection of corneal endothelium from apoptosis using gene and cell therapy is in a translational phase. This approach offers advantages for eye banking and…”
    Get full text
    Journal Article
  17. 17

    Evaluation of corneal biomechanics in keratoconus using dynamic ultra-high-speed Scheimpflug measurements by Brettl, S, Franko Zeitz, P, Fuchsluger, T A

    “…The in vivo analysis of corneal biomechanics in patients with keratoconus is especially of interest with respect to diagnosis, follow-up and monitoring of the…”
    Get full text
    Journal Article
  18. 18

    Penetrating keratoplasty – long‐term follow‐up data in low and high risk keratoplasties by FUCHSLUGER, T

    Published in Acta ophthalmologica (Oxford, England) (01-09-2014)
    “…The talk will present long‐term follow up data from the Dusseldorf Graft Registry on graft survival and outcome. Both low and high risk keratoplasty cases will…”
    Get full text
    Journal Article
  19. 19

    Novel cell therapeutical approaches to treat the corneal endothelium by FUCHSLUGER, T

    Published in Acta ophthalmologica (Oxford, England) (01-09-2014)
    “…The talk will give an overview of cell therapeutical treatments of corneal endothelial cells. The use of different vectors in nano‐scale will be presented…”
    Get full text
    Journal Article
  20. 20

    Nanoparticles for delivery of therapeutical nucleic acids to corneal endothelium by CZUGALA, M, MYKHAYLYK, O, SINGER, BB, STEUHL, KP, ERGÜN, S, WESSELBORG, S, EPPLE, M, PLANK, C, FUCHSLUGER, TA

    Published in Acta ophthalmologica (Oxford, England) (01-08-2013)
    “…Corneal endothelium is as crucial for maintenance of corneal function as difficult it is to be accessed with any treatment that doesn’t involve invasive…”
    Get full text
    Journal Article